Skip to content
10-Q

Quarterly Report

CALLISTO PHARMACEUTICALS INC

0001104659-12-037395

← back to feed
Filed
May 15, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · May 14, 2012 158.52M sh
Shares Diluted Q1 2012 · Mar 31, 2012 158.52M sh
Shares Diluted Q1 2012 · Mar 31, 2011 157.65M sh
Capex Q1 2012 · Mar 31, 2012 $117.23K
Cash And Equivalents Q1 2012 · Mar 31, 2012 $6.12M
Cash And Equivalents Q1 2012 · Dec 31, 2011 $13.24M
Cash And Equivalents Q1 2012 · Mar 31, 2011 $938.78K
Cash And Equivalents Q1 2012 · Dec 31, 2010 $1.71M
Stockholders Equity Q1 2012 · Mar 31, 2012 $23.49M
Stockholders Equity Q1 2012 · Dec 31, 2011 $26.18M
Current Liabilities Q1 2012 · Mar 31, 2012 $4.85M
Current Liabilities Q1 2012 · Dec 31, 2011 $4.66M
Total Liabilities Q1 2012 · Mar 31, 2012 $8.17M
Total Liabilities Q1 2012 · Dec 31, 2011 $7.99M
Current Assets Q1 2012 · Mar 31, 2012 $7.77M
Current Assets Q1 2012 · Dec 31, 2011 $14.42M
Total Assets Q1 2012 · Mar 31, 2012 $7.86M
Total Assets Q1 2012 · Dec 31, 2011 $14.51M
Sga Expense Q1 2012 · Mar 31, 2012 $1.95M
Sga Expense Q1 2012 · Mar 31, 2012 $62.33M
Sga Expense Q1 2012 · Mar 31, 2011 $1.96M
Net Income Q1 2012 · Mar 31, 2012 −$3.14M
Net Income Q1 2012 · Mar 31, 2012 −$126.4M
Net Income Q1 2012 · Mar 31, 2011 −$1.76M
Operating Income Q1 2012 · Mar 31, 2012 −$7.29M
Operating Income Q1 2012 · Mar 31, 2012 −$132.57M
Operating Income Q1 2012 · Mar 31, 2011 −$3.33M